Saturday, July 11, 2026

Drug profile · INN

gallium nitrate

gallium nitrate (GANITE) is a ribonucleoside-diphosphate reductase rr1 inhibitor. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — gallium nitrate
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

gallium nitrate (GANITE) is a ribonucleoside-diphosphate reductase rr1 inhibitor. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN gallium nitrate
Brand GANITE
Mechanism Ribonucleoside-diphosphate reductase RR1 inhibitor
Target Hydroxyapatite
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Ribonucleoside-diphosphate reductase RR1 inhibitor

Primary target: Hydroxyapatite

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is gallium nitrate?

gallium nitrate (GANITE) is a ribonucleoside-diphosphate reductase rr1 inhibitor. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for gallium nitrate?

GANITE is a marketed brand name for gallium nitrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of gallium nitrate?

gallium nitrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.